Promising results for cancer-immunotherapies revealed!

Promising news on the immunotherapies front! Impressive results have been published last week regarding two new immunotherapies, pembrolizumab and nivolumab, treating patients diagnosed with melanoma, non-small cell lung cancer and renal cancer.

Data from phase 3 trials for the breakthrough immunotherapies pembrolizumab and nivolumab have shown exiting results for the treatment of melanoma, non-small cell lung cancer and renal cancer. The data was presented last week at the convention of the American Society of Clinical Oncology (ASCO) 2015.

Many media have reported about these results, a short overview can be found below:

New Class of Drugs Shows More Promise in Treating Cancer  New York Times By Andrew Pollack, May 29, 2015
Lung cancer therapy is 'milestone' BBC By James Gallagher, May 30, 2015

Bristol-Myers Squibb Has A Cancer Breakthrough. Here's Why It Should Cut The Price  Forbes By Matthey Herper, June 1, 2015

©TheSocialMedwork





Comments

115


Comment



Related Articles

Telling your child you have cancer

Suggestions from cancer survivors and their children


Dealing with a Diagnosis

Online counsellor Nicole Hind shares how to help our brains and bodies deal with a diagnosis


Science saves lives!

Top 5 medical breakthroughs from the past, present and future


Registered with the Dutch Ministry of Health as an independent intermediary, Registration number 6730 BEM



Share our website

Follow us


DISCLAIMER: The Services of TheSocialMedwork do not replace a physician-patient relationship and are not intended as medical advice. TheSocialMedwork provides patients and physicians with existing treatment options abroad and creates access to these options after the patient and physician have made a professional decision. Privacy Policy / Terms and Conditions
Our service uses cookies.